Back
Salesforce Vs. Regeneron Pharmaceuticals Industry Stock Comparison
Sell
30
CRM
Salesforce
Last Price:
$260.66
Seasonality Move:
9.77%
Sell
37
REGN
Regeneron Pharmaceuticals
Last Price:
$509.69
Seasonality Move:
9.62%
Sell
30
Salesforce (CRM)
is a Sell
Is Salesforce a Buy, Sell or Hold?
-
The current Salesforce [CRM] share price is $260.63. The Score for CRM is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
CRM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals [REGN] share price is $513.58. The Score for REGN is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRM Stock Price Chart
What is Salesforce's stock price today?
-
The Salesforce share price today is $260.63The current trend is moderately bearish and CRM is experiencing slight selling pressure.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $513.58Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
CRM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.37 | Sell |
Relative Strength Index (14 RSI): | 41.71 | Sell |
Chaikin Money Flow: | -3099468 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
REGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -16.83 | Sell |
Relative Strength Index (14 RSI): | 42.15 | Sell |
Chaikin Money Flow: | 250436 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
CRM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 263.28 | Sell |
20-day SMA: | 267.57 | Sell |
50-day SMA: | 268.61 | Sell |
200-day SMA: | 295.53 | Sell |
8-day EMA: | 263.11 | Sell |
20-day EMA: | 266.64 | Sell |
50-day EMA: | 248.26 | Buy |
200-day EMA: | 127.07 | Buy |
REGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 519.49 | Sell |
20-day SMA: | 533.82 | Sell |
50-day SMA: | 559.47 | Sell |
200-day SMA: | 753.36 | Sell |
8-day EMA: | 517.09 | Sell |
20-day EMA: | 530.41 | Sell |
50-day EMA: | 563.49 | Sell |
200-day EMA: | 708.01 | Sell |
Salesforce Earnings Growth & CRM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.23 per share, an increase this year of $1.83 per share, and an increase next year of $1.26 per share.
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.42 per share, a decrease next quarter of $0.05 per share, a decrease this year of $9.47 per share, and an increase next year of $4.72 per share.
Salesforce Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regeneron Pharmaceuticals Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |